The 62-patient multicentre trial is evaluating a nanoparticle-based platform designed to help identify sentinel lymph nodes in gastric and oesophageal cancer surgery....
The information contained herein represents a summary of the peer-reviewed journal article published in Thrombosis and Haemostasis entitled "Clinical Validation of a Point-of-Care Whole Blood Coagulometer in Patients on Factor Xa Inhibitors"...
ALZpath’s proprietary p-tau217 antibody has been extensively studied in peer-reviewed research and is being integrated into automated in vitro diagnostic platforms ...
The CART blood pressure monitor enables continuous BP tracking even in AF and HF patients ...
These approvals further strengthen Fujirebio’s comprehensive neurological diagnostics portfolio by broadening access to high-quality biomarker solutions ...
This underscores an urgent need for a broader range of novel and efficacious treatment options...
The randomised NATURE trial found that enVast-assisted mechanical thrombectomy reduced infarct size compared with conventional PCI in STEMI patients with a large thrombus burden....
The C22 features a 5 kW/110 kHz generator, with pulsed fluoroscopy of up to 40 mA and 30 frames per second (fps)...
The FDA IDE study is evaluating pulmonary artery denervation in patients with combined pre- and post-capillary pulmonary hypertension associated with left heart disease....
The milestone marks the initiation of the IDE study, representing a major step forward in the clinical advancement of the PADN procedure...
